Elekta AB (EKTAF)
5.88
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.247B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 28.92% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 1.261 |
| Price to Book Value | 2.928 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.1255 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.033 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 65.99% |
Profile
| Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden. |
| URL | http://www.elekta.com |
| Investor Relations URL | https://www.elekta.com/investors/ |
| HQ State/Province | Sodermanland |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Core |
| Next Earnings Release | Aug. 27, 2026 |
| Last Earnings Release | May. 28, 2026 |
| Next Ex-Dividend Date | Sep. 04, 2026 |
| Last Ex-Dividend Date | Mar. 06, 2026 |
Profile
| Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden. |
| URL | http://www.elekta.com |
| Investor Relations URL | https://www.elekta.com/investors/ |
| HQ State/Province | Sodermanland |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Core |
| Next Earnings Release | Aug. 27, 2026 |
| Last Earnings Release | May. 28, 2026 |
| Next Ex-Dividend Date | Sep. 04, 2026 |
| Last Ex-Dividend Date | Mar. 06, 2026 |